Two-Thirds of Eligible Lung Cancer Patients Miss Guideline-Backed Infection Shield, French Data Show
A nationwide analysis of French hospital cohorts finds that only about two-thirds of small-cell lung cancer patients eligible for G-CSF ...
A nationwide analysis of French hospital cohorts finds that only about two-thirds of small-cell lung cancer patients eligible for G-CSF ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.